IShares IBonds Financials
| IBHG Etf | USD 22.51 0.07 0.31% |
Net Expense Ratio 0.0035 |
IShares |
The data published in IShares IBonds' official financial statements typically reflect IShares IBonds' business processes, product offerings, services, and other fundamental events. However, there are additional fundamental indicators that are easier to understand and visualize along the underlying realities that are driving IShares IBonds' quantitative information. For example, before you start analyzing numbers published by IShares accountants, it's essential to understand IShares IBonds' liquidity, profitability, and earnings quality within the context of the iShares space in which it operates.
IShares IBonds Etf Summary
IShares IBonds competes with Xtrackers High, and Xtrackers Short. The index is composed of U.S. dollar-denominated, taxable, fixed-rate, high yield and BBB or equivalently rated corporate bonds scheduled to mature between January 1, 2027 and December 15, 2027, inclusive. Ishares Ibonds is traded on BATS Exchange in the United States.| Instrument | USA Etf View All |
| Exchange | BATS Exchange |
| ISIN | US46436E4787 |
| CUSIP | 46436E478 |
| Region | North America |
| Investment Issuer | iShares |
| Location | California; U.S.A |
| Business Address | 400 Howard Street |
| Etf Family | iShares |
| Fund Category | Corporate |
| Portfolio Concentration | High Yield |
| Benchmark | Dow Jones Industrial |
| Phone | NA |
| Currency | USD - US Dollar |
IShares IBonds Key Financial Ratios
| Beta | 0.76 | |||
| Last Dividend Paid | 0.0921 |
IShares Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining IShares IBonds's current stock value. Our valuation model uses many indicators to compare IShares IBonds value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across IShares IBonds competition to find correlations between indicators driving IShares IBonds's intrinsic value. More Info.iShares iBonds 2027 is rated second overall ETF in beta as compared to similar ETFs. It is rated third overall ETF in one year return as compared to similar ETFs reporting about 13.55 of One Year Return per Beta. Comparative valuation analysis is a catch-all technique that is used if you cannot value IShares IBonds by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.iShares iBonds 2027 Systematic Risk
IShares IBonds' systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. IShares IBonds volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was ten with a total number of output elements of fifty-one. The Beta measures systematic risk based on how returns on iShares iBonds 2027 correlated with the market. If Beta is less than 0 IShares IBonds generally moves in the opposite direction as compared to the market. If IShares IBonds Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one iShares iBonds 2027 is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of IShares IBonds is generally in the same direction as the market. If Beta > 1 IShares IBonds moves generally in the same direction as, but more than the movement of the benchmark.
About IShares IBonds Financials
What exactly are IShares IBonds Financials? Typically, a company's financial statements are the reports that show the financial position of the company. Three primary documents fall into the category of financial statements. These documents include IShares IBonds' income statement, its balance sheet, and the statement of cash flows. Potential IShares IBonds investors and stakeholders use financial statements to determine how well the company is positioned to perform in the future. Although IShares IBonds investors may use each financial statement separately, they are all related. The changes in IShares IBonds's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on IShares IBonds's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. Please read more on our technical analysis and fundamental analysis pages.IShares IBonds Thematic Clasifications
iShares iBonds 2027 is part of several thematic ideas from Corporate ETFs to High Yield ETFs. If you are a theme-oriented, socially responsible, and at the same time, a result-driven investor, you can align your investing habits with your values without jeopardizing your expectations about returns. You can easily create an optimal portfolio of stocks, ETFs, funds, or cryptocurrencies based on a specific theme of your liking. Get More Thematic IdeasIShares IBonds November 30, 2024 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of IShares IBonds help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of iShares iBonds 2027. We use our internally-developed statistical techniques to arrive at the intrinsic value of iShares iBonds 2027 based on widely used predictive technical indicators. In general, we focus on analyzing IShares Etf price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build IShares IBonds's daily price indicators and compare them against related drivers.
| Downside Deviation | 0.1704 | |||
| Information Ratio | (0.66) | |||
| Maximum Drawdown | 0.6241 | |||
| Value At Risk | (0.27) | |||
| Potential Upside | 0.2693 |
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in iShares iBonds 2027. Also, note that the market value of any etf could be closely tied with the direction of predictive economic indicators such as signals in rate. You can also try the Cryptocurrency Center module to build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency.
The market value of iShares iBonds 2027 is measured differently than its book value, which is the value of IShares that is recorded on the company's balance sheet. Investors also form their own opinion of IShares IBonds' value that differs from its market value or its book value, called intrinsic value, which is IShares IBonds' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because IShares IBonds' market value can be influenced by many factors that don't directly affect IShares IBonds' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between IShares IBonds' value and its price as these two are different measures arrived at by different means. Investors typically determine if IShares IBonds is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, IShares IBonds' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.